Clinical trial
Pentoxifylline for Treatment of Resistant Major Depression: A Randomized, Double Blind, Placebo Controlled Trial
NCT05324735 is registered in ClinicalTrials.gov with Hawler Medical University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Pentoxifylline for Treatment of Resistant Major Depression: A Randomized, Double Blind, Placebo Controlled Trial
- Lead sponsor
- Hawler Medical University
- Phase
- Phase 1/2
- Overall status
- Completed
- Start date
- December 15, 2021
- Completion date
- June 4, 2022
- Enrollment
- 60 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
resistant major depression